186 related articles for article (PubMed ID: 32945371)
1. NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer.
Xiong Q; Fan S; Duan L; Liu B; Jiang X; Chen X; Xiong C; Tao Q; Wang J; Zhang H; Chen C; Duan Y
Mol Med Rep; 2020 Oct; 22(4):2916-2924. PubMed ID: 32945371
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
[TBL] [Abstract][Full Text] [Related]
3. NCAPH Is Required for Proliferation, Migration and Invasion of Non-small-cell Lung Cancer Cells.
Kim B; Kim SW; Lim JY; Park SJ
Anticancer Res; 2020 Jun; 40(6):3239-3246. PubMed ID: 32487618
[TBL] [Abstract][Full Text] [Related]
4. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
Qiu X; Gao Z; Shao J; Li H
Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
7. Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer.
Yang J; Li Y; Khoury T; Alrawi S; Goodrich DW; Tan D
Ann Clin Lab Sci; 2008; 38(2):105-12. PubMed ID: 18469354
[TBL] [Abstract][Full Text] [Related]
8. NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma.
Li C; Meng J; Zhang T
Sci Rep; 2022 Jun; 12(1):9578. PubMed ID: 35688915
[TBL] [Abstract][Full Text] [Related]
9. Copy-number variation of MCL1 predicts overall survival of non-small-cell lung cancer in a Southern Chinese population.
Yin J; Li Y; Zhao H; Qin Q; Li X; Huang J; Shi Y; Gong S; Liu L; Fu X; Nie S; Wei S
Cancer Med; 2016 Sep; 5(9):2171-9. PubMed ID: 27264345
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
[TBL] [Abstract][Full Text] [Related]
11. Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer.
Allen TD; Zhu CQ; Jones KD; Yanagawa N; Tsao MS; Bishop JM
Cancer Res; 2011 Mar; 71(6):2212-21. PubMed ID: 21406400
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
[TBL] [Abstract][Full Text] [Related]
13. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
Ogura T; Azuma K; Sato J; Kinowaki K; Takayama KI; Takeiwa T; Kawabata H; Inoue S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768935
[TBL] [Abstract][Full Text] [Related]
14. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
16. AP‑4 predicts poor prognosis in non‑small cell lung cancer.
Gong H; Han S; Yao H; Zhao H; Wang Y
Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973
[TBL] [Abstract][Full Text] [Related]
17. Identification of NCAPH as a biomarker for prognosis of breast cancer.
Lu H; Shi C; Wang S; Yang C; Wan X; Luo Y; Tian L; Li L
Mol Biol Rep; 2020 Oct; 47(10):7831-7842. PubMed ID: 33009967
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.
Qiu ZX; Wang L; Han J; Liu D; Huang W; Altaf K; Qiu XS; Javed MA; Zheng J; Chen BJ; Li WM
Cancer Sci; 2012 Oct; 103(10):1774-9. PubMed ID: 22738312
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of S100A9 overexpression in non-small cell lung cancer.
Kawai H; Minamiya Y; Takahashi N
Tumour Biol; 2011 Aug; 32(4):641-6. PubMed ID: 21369941
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer.
Nakano T; Go T; Nakashima N; Liu D; Yokomise H
Anticancer Res; 2020 Feb; 40(2):1007-1014. PubMed ID: 32014946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
